Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Brandon Couillard
WF
Brandon Couillard
Wall Street Analyst
★☆☆☆☆
#2428
on 13Foresight · ranked by our own returns
37%
Success Rate
-9.2%
Average Return
13 of 35 calls profitable · -17.5% vs benchmark
📈 Across the calls we could measure, roughly 37% of Brandon Couillard's ratings turned a profit when each position was held for 1 year — averaging -9.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

40 Buy 44 Hold 0 Sell
Brandon's Stock Coverage 35 ratings · 2026-06-19
Company Date Position Consensus Price Target 1-Yr Return
GH
Guardant Health
Jun 17, 2026 BUY Strong Buy
-5.8% avg upside
30 analysts
$125.00
5.11% Downside
+0.0%
MLAB
Mesa Laboratories
May 28, 2026 HOLD Buy
+48.3% avg upside
5 analysts
$94.00
1.20% Downside
+0.9%
A
Agilent
May 28, 2026 BUY Strong Buy
+3.9% avg upside
32 analysts
$160.00
25.98% Upside
-2.0%
BLLN
BillionToOne, Inc. Class A
May 22, 2026 HOLD Strong Buy
+16.4% avg upside
8 analysts
$90.00
14.47% Downside
+17.7%
BIO
Bio-Rad Laboratories
May 22, 2026 HOLD Buy
+23.7% avg upside
8 analysts
$310.00
9.81% Upside
-1.1%
TMO
Thermo Fisher
May 21, 2026 BUY Strong Buy
+26.9% avg upside
38 analysts
$615.00
32.43% Upside
+2.8%
WAT
Waters
May 14, 2026 HOLD Strong Buy
+3.5% avg upside
30 analysts
$370.00
4.09% Upside
+7.4%
NTRA
Natera
May 08, 2026 HOLD Strong Buy
+7.6% avg upside
26 analysts
$220.00
4.87% Downside
+16.6%
TECH
Bio-Techne
May 07, 2026 BUY Strong Buy
+38.6% avg upside
21 analysts
$62.00
7.06% Upside
+10.3%
MYGN
Myriad Genetics
May 06, 2026 HOLD Hold
+315.3% avg upside
24 analysts
$5.50
21.17% Upside
-4.9%
WGS
GeneDx Holdings
May 05, 2026 BUY Strong Buy
+35.9% avg upside
9 analysts
$75.00
27.01% Upside
+77.7%
DHR
Danaher
Apr 22, 2026 HOLD Strong Buy
+21.8% avg upside
45 analysts
$212.00
19.59% Upside
-1.5%
RGEN
Repligen
Feb 25, 2026 BUY Strong Buy
+28.3% avg upside
25 analysts
$180.00
36.43% Upside
-7.4%
CDNA
CareDx
Feb 25, 2026 HOLD Buy
+26.1% avg upside
16 analysts
$21.00
19.71% Downside
+25.9%
AVTR
Avantor
Feb 13, 2026 BUY Buy
+49.6% avg upside
26 analysts
$14.00
46.16% Upside
+4.7%
RVTY
Revvity
Feb 03, 2026 HOLD Buy
+5.5% avg upside
23 analysts
$110.00
10.05% Upside
-3.2%
MTD
Mettler-Toledo
Dec 15, 2025 HOLD Buy
+2.7% avg upside
18 analysts
$1450.00
26.60% Upside
-18.3%
BRKR
Bruker
Dec 15, 2025 BUY Buy
-7.0% avg upside
22 analysts
$55.00
3.83% Downside
+20.0%
MRVI
Maravai Lifesciences Holdings
Dec 15, 2025 BUY Strong Buy
+175.0% avg upside
17 analysts
$4.50
13.39% Downside
+13.1%
CYRX
CryoPort
Mar 13, 2024 BUY Strong Buy
-3.8% avg upside
15 analysts
$17.00
13.23% Upside
-56.5%
HSIC
Henry Schein
Mar 06, 2024 HOLD Buy
+7.4% avg upside
25 analysts
$81.00
1.43% Upside
-3.1%
XRAY
DENTSPLY SIRONA
Feb 29, 2024 BUY Buy
+171.7% avg upside
25 analysts
$37.50
262.96% Upside
-48.0%
NVST
Envista Holdings
Feb 09, 2024 HOLD Buy
+13.6% avg upside
19 analysts
$23.00
11.13% Downside
-3.1%
ALGN
Align Tech
Feb 01, 2024 BUY Strong Buy
+58.0% avg upside
21 analysts
$325.00
78.40% Upside
-19.9%
TBIO
Telesis Bio
Aug 11, 2023 BUY Strong Buy
+7199900.0% avg upside
7 analysts
$72.00
7199899.99% Upside
-4.9%
SDCCQ
SmileDirectClub
May 10, 2023 HOLD Sell
+513999900.0% avg upside
10 analysts
$0.60
59999900.09% Upside
·
KEYS
Keysight Technologies
Aug 29, 2022 BUY Strong Buy
-10.6% avg upside
16 analysts
$200.00
44.98% Downside
-20.5%
NAUT
Nautilus Biotechnolgy
May 04, 2022 BUY Strong Buy
+404.4% avg upside
5 analysts
$11.00
382.40% Upside
-51.3%
CDXS
Codexis
Jun 18, 2021 BUY Strong Buy
+291.5% avg upside
13 analysts
$26.00
911.69% Upside
-59.1%
OSUR
Orasure Technologies
Aug 06, 2020 HOLD Buy
+99.5% avg upside
11 analysts
$15.00
252.89% Upside
·
BDX
Becton Dickinson
May 18, 2020 BUY Buy
+35.6% avg upside
25 analysts
$300.00
108.43% Upside
-7.3%
OPK
Opko Health
Aug 08, 2018 HOLD Strong Buy
+374.3% avg upside
12 analysts
$4.50
216.97% Upside
-65.2%
VIVS
VivoSim Labs
Jul 27, 2018 BUY Buy
+156.6% avg upside
5 analysts
$1.75
59.17% Upside
-63.6%
BMRN
BioMarin Pharmaceutical
May 31, 2017 BUY Strong Buy
+72.7% avg upside
52 analysts
$116.00
112.12% Upside
+3.1%
QGEN
Qiagen
Nov 22, 2016 HOLD Buy
+14.1% avg upside
23 analysts
$26.00
29.64% Downside
+15.8%
🔒 30 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Brandon Couillard — Frequently Asked Questions
How accurate are Brandon Couillard's stock ratings?
Based on the calls 13Foresight could measure, about 37% of Brandon's ratings were profitable over a one-year hold, with an average return of -9.2% per rating, or -17.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Brandon ranked on 13Foresight?
Brandon Couillard is currently ranked #2428 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Brandon cover?
Brandon most recently has ratings on GH, MLAB, A, BLLN, BIO, TMO, WAT, NTRA, TECH, MYGN, WGS, DHR and 23 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.